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Abstract
Salmonella and Shigella bacteria require the type III secretion system (T3SS) to inject virulence
proteins into their hosts and initiate infections. The tip proteins SipD and IpaD are critical
components of the Salmonella and Shigella T3SS, respectively. Recently, SipD and IpaD have
been shown to interact with bile salts, which are enriched in the intestines, and are hypothesized to
act as environmental sensors for these enteric pathogens. Bile salts activate the Shigella T3SS but
repress the Salmonella T3SS, and the mechanism of this differing response to bile salts is poorly
understood. Further, how SipD binds to bile salts is currently unknown. Computer modeling
predicted that IpaD binds the bile salt deoxycholate in a cleft formed by the N-terminal domain
and the long central coiled coil of IpaD. Here, we used NMR methods to determine which SipD
residues are affected by the interaction with the bile salts deoxycholate, chenodeoxycholate and
taurodeoxcholate. The bile salts perturbed nearly the same set of SipD residues, however, the
largest chemical shift perturbations occurred away from what was predicted for the bile salt
binding site in IpaD. Our NMR results indicate that that bile salt interaction of SipD will be
different from what was predicted for IpaD, suggesting a possible mechanism for the differing
response of Salmonella and Shigella to bile salts.
The type III secretion system (T3SS) is essential in the pathogenesis of many Gram-negative
bacteria (1) and it consists of a needle apparatus, which is a nanometer-scale bacterial
injector found on the bacterial surface. A structural component of the T3SS needle apparatus
is the tip protein (2, 3), which is known as SipD in Salmonella typhimurium, IpaD in
Shigella flexneri (3), and BipD in Burkholderia pseudomallei. The tip proteins are critical in
the assembly of the T3SS needle apparatus and in bacterial pathogenesis (4–6). Recently,
IpaD was shown to bind the bile salts deoxycholate, taurodeoxycholate and
chenodeoxycholate (7); and this specific binding was suggested to function as an
environmental signal to activate the T3SS in Shigella flexneri (8). The same study also
showed that SipD binds to deoxycholate (7), however, other studies have shown that bile
salts suppressed the invasiveness of Salmonella (9, 10). The crystal structures of IpaD (11)
and SipD (to be reported elsewhere) are highly similar (with Cα RMSD of 1.4 Å), thus it is
not clear how bile salts would interact with IpaD and SipD to induce opposing effects –
activation of the Shigella T3SS and inactivation the Salmonella T3SS.
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Using computer docking simulation, Stensrud et al. (7) predicted that deoxycholate binds
IpaD in a cleft formed by the central coiled-coil and the N-terminal domain of IpaD, which
was then confirmed by fluorescence spectroscopy and mutagenesis (7). Here, we used NMR
methods to identify which SipD residues are involved in the interaction with bile salts
deoxycholate, taurodeoxycholate and chenodeoxycholate. Our NMR results indicated that
bile salts bind SipD in a different site from what is predicted for IpaD, suggesting a basis for
the differing mechanism of bile salt interaction observed for Shigella and Salmonella.
EXPERIMENTAL PROCEDURES
Protein expression and purification
The coding region for wild type Salmonella typhimurium SipD residues 39 to 343 was PCR
amplified and subcloned into pET-21a with a His6-tagged GB1 domain and a tobacco etch
virus (TEV) protease cleavage site appended at the N-terminus of SipD39–343 (after cleavage
of the fusion tag, SipD39–343 retained a three-residue cloning artifact “GHM” at its N-
terminus). All growth media contained 30 µg/mL kanamycin and 100 µg/mL carbenicillin.
For protein expression, the SipD39–343 expression plasmid was transformed into E. coli
BL21(DE3) DNAY and a starter culture was grown at 37°C overnight in 20 mL LB medium
followed by centrifugation. Perdeuterated 15N,13C-labeled SipD39–343 was obtained
resuspending the starter culture in 1 L M9 minimal media dissolved in 99% D2O
(Cambridge Isotopes) and supplemented with 2 g/L of 13C-glucose (Isotec) and 1 g/L
of 15N-ammonium chloride (Isotec). Isotopically 15N-labeled SipD39–343 was obtained by
resuspending the starter culture in 1 L M9 minimal medium supplemented with 1 g/L 15N-
ammonium chloride. Cells were grown at 37°C until A600 ~ 0.6 to 0.8, induced with 1 mM
IPTG and cell growth was continued in a 15°C shaker incubator overnight. Cells were
harvested by centrifugation, resuspended in 30 mL binding buffer (500 mM NaCl, 20 mM
Tris-HCl, 500 mM NaCl, 5 mM imidazole, pH 8.0) and stored at −20°C. To purify
SipD39–343, cells were thawed on ice and 40 µL of 1 mM phenylmethylsulfonyl fluoride was
added before sonication. The cell lysate was centrifuged (18,200 ×g, 10 min, 4°C), and 1/10
volume of 1% polyethyleneimine (pH 8) was added to the supernatant to precipitate the
nucleic acids, then centrifuged (18,200 ×g, 10 min, 4°C). The supernatant was loaded onto a
5 mL Ni2+-affinity column (Sigma), washed with 35 mL binding buffer, and eluted in 1 mL
fractions with a total of 15 mL elution buffer (250 mM imidazole, 500 mM NaCl, 20 mM
Tris, pH 8.0). Fractions containing the GB1-SipD39–343 fusion protein were combined (into
a total volume of 20 mL) and dialyzed overnight at room temperature in 1 L buffer (50mM
Tris, 0.5 mM EDTA, 1mM DTT, 20 mM NaCl pH 8) in the presence of 50 uL 0.07 mM
recombinant TEV protease that was purified as described (12). The digest was loaded onto a
5 mL Ni2+-affinity column, which retained the GB1 tag and eluted SipD39–343. Purified
SipD39–343 was dialyzed in buffer (10 mM sodium phosphate pH 6.5 and 10 mM NaCl),
concentrated using Amicon Ultra 3K (Millipore) and protein concentration was determined
by UV absorbance at 280 nm.
Amino acid specific labeling
In total, eight 15N-amino acid-specific labeled SipD39–343 were prepared using 15N-labeled
Leu, Val, Ile, Ala, Phe, Tyr, Met and Lys. To label SipD39–343 with 15N-Leu, for example,
E. coli BL21(DE3) DNAY harboring the SipD39–343 expression plasmid was grown in 1 L
LB medium overnight at 37°C. The cells were harvested by centrifugation and resuspended
in 500 mL M9 minimal medium supplemented with 125 mg/L of 15N-Leu (Isotec) and 600
mg/L of the rest of the 19 unlabeled amino acids. The cells were grown at 37°C for ~45 min
until A600 ~0.8, induced with 1 mM IPTG and cell growth was continued at 37 °C for 4
hours before harvest. Protein was purified as described above.
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Mutagenesis of tryptophan residues
To assign the side chain resonances of the four tryptophan residues in SipD (W135, W177,
W234 and W290), each tryptophan was mutated into tyrosine by the Stratagene
Quickchange method. Recombinant 15N-labeled SipD39–343 with point mutation W135Y,
W177Y, W234Y or W290Y was expressed and purified as described above.
NMR spectroscopy
NMR data were acquired at 30°C on a Bruker Avance 800 MHz equipped with cryogenic
triple-resonance probe, processed using NMRPipe (13) and analyzed using NMRView (14).
Proteins were dissolved in NMR buffer (10 mM sodium phosphate pH 6.5, 10 mM NaCl,
and 10% D2O). For backbone assignments, 0.5 mM perdeuterated 15N,13C-SipD39– 343 was
used to acquire 2D 1H-15N TROSY-HSQC (15), 3D TROSY-HNCA (16), 3D TROSY-
HNCACB (17), 3D TROSY-HNCO (17) and 3D TROSY-HN(CA)CO (17). In addition,
2D 1H-15N TROSY-HSQC (15) was acquired using 0.3 – 0.6 mM 15N-amino acid-labeled
SipD39–343. Tryptophan side chains were assigned by acquiring 2D 1H-15N HSQC or
2D 1H-15N TROSY-HSQC (15) using 15N-labeled SipD39–343 W135Y, W177Y, W234Y
and W290Y. For NMR chemical shift mapping, 2D 1H-15N TROSY-HSQC (15) spectra
were acquired using 15N-labeled SipD39–343 that was titrated with varying amounts of
deoxycholate (Amresco), chenodeoxycholate (Sigma), taurodeoxycholate (Sigma) or cholate
hydrate (Sigma). NMR samples for chemical shift mapping were prepared as follows: 0.6
mM 15N-SipD39–343 was dialyzed overnight in 1 L of NMR buffer containing increasing
concentrations of deoxycholate (0, 0.7, 1.4 or 2.1 mM) or chenodeoxycholate (0.0, 0.3, 0.6,
1.3 or 2.6 mM); and 0.7 mM 15N-SipD39– 343 in NMR buffer with taurodeoxycholate (0.0,
0.3, 0.7, 1.3 or 2.6 mM) or cholate hydrate (0.0, 0.3, 0.7, 1.3 or 2.6 mM).
RESULTS
Protein expression and purification
Full-length SipD yielded poor NMR spectra (Fig. S1) and was not amenable for NMR
characterization. However the crystal structures of BipD (11, 18) and IpaD (11) showed that
the N-terminal 29 – 38 residues were disordered and these proteins were predominantly
alpha helical in secondary structure. Thus, the N-terminal 38 residues of SipD were
truncated, forming the SipD39–343 construct used in this study. Recombinant SipD39–343 was
overexpressed as a fusion protein with the GB1 domain, purified by Ni2+-affinity
chromatography and digested with TEV protease to remove the fusion tag. The circular
dichroism (CD) spectra of full-length SipD and SipD39–343 were both indicative of highly
alpha helical proteins (Fig. S2). Further, the CD thermal denaturation curves for full-length
SipD and SipD39–343 (Fig. S2) were similar in pattern and showed two transition
temperatures at 59°C and 75°C. Thus, CD spectroscopy indicated that SipD39–343 retained
the core structured domain of SipD. In contrast to full-length SipD, the truncated SipD39–343
yielded well-dispersed NMR spectra (Fig. 1 & Fig. S1C), which allowed further NMR
characterization.
NMR assignment of SipD39–343
The backbone resonances of SipD39–343 (305 residues) were assigned using perdeuteration,
TROSY NMR (Fig. S3) and 15N-amino acid-specific labeling (Fig S4). The backbone
amides of 274 residues, or 93% of 295 non-proline residues in SipD39–343, were assigned.
The remaining 7% of backbone amides that could not be assigned were due to peak overlap
or peak broadening, and these residues were: Arg (41); Leu (48); Thr (65); Glu (103); His
(40 and 56); Gln (57 and 262); Asn (72 and 104) and Ser (47, 49, 86, 143, 243, 250, 313,
317, 332 and 333). Nevertheless, nearly complete assignment of the backbone amides
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allowed the assignment of 93% of the Cα, Cβ and C’ resonances of SipD39–343. The
secondary Cα, Cβ and C’ chemical shifts of SipD39–343 (Fig. 2) showed a predominantly
alpha helical protein with several short beta strands, which correlated well with the
secondary structures of BipD (11, 18) and IpaD (11). The chemical shifts suggested that the
three dimensional structure of SipD in solution will be similar to that of the crystal structures
of BipD (11, 18) and IpaD (11). Indeed, our 1.9 Å resolution crystal structure of SipD39–343
(to be reported elsewhere) showed similar secondary structures as indicated by the Cα, Cβ
and C’ chemical shifts. Additionally, our SipD crystal structure showed a similar pattern of
secondary structures with the IpaD crystal structure (Fig. S5) indicating that SipD and IpaD
are structurally similar. However, in our SipD39–343 crystal structure, residues 118–133,
which connect the N-terminal domain with the central coiled coil, lacked electron density
and were disordered in the SipD39–343 crystal. To assign the tryptophan side chain, the four
tryptophan residues (W135, W177, W234 and W290) were each mutated into a tyrosine
residue. Proton-nitrogen correlation spectra showed that the tryptophan to tyrosine point
mutants were folded, which allowed the assignment of the tryptophan residues in SipD (Fig.
S6).
NMR titrations of SipD39–343 with bile salts
We used NMR chemical shift mapping to investigate the SipD interaction with bile salts
deoxycholate, taurodeoxycholate, chenodeoxycholate and cholate hydrate. 15N-labeled
SipD39–343 was dialyzed in buffer with increasing amounts of bile salts and 2D 1H-15N
TROSY spectra were acquired. The protein-bile salt molar ratios used in the NMR titrations
were limited by the critical micelle concentrations of deoxycholate (5 mM) (19),
taurodeoxycholate (2.5 mM) (20) and chenodeoxycholate (7 mM) (19) (in contrast, the
critical micelle concentration of cholate hydrate is 18 mM (19)). SipD39–343 titrated with
deoxycholate (Fig. 1), taurodeoxycholate (Fig. S7) and chenodeoxycholate (Fig. S8) showed
many residues with chemical shift perturbations with increasing amounts of bile salts;
whereas titration with cholate hydrate (Fig. S9) showed only minor chemical shift changes
for one residue (L179) and generally no chemical shift perturbation for the rest of
SipD39–343. Thus, NMR titrations suggested specific interaction of SipD39–343 with the
deoxycholate (Fig. 1), taurodeoxycholate (Fig. S7) and chenodeoxycholate (Fig. S8) but not
with cholate hydrate (Fig. S9). Further, the interactions were in fast exchange NMR time
scale as indicated by the progressive changes in the SipD39–343 peak positions with
increasing amounts of deoxycholate (Fig. 1), taurodeoxycholate (Fig. S7) and
chenodeoxcholate (Fig. S8).
We identified all the backbone amides and the tryptophan side chain of SipD39–343 that were
perturbed by deoxycholate, taurodeoxycholate and chenodeoxycholate. In the presence of
deoxycholate, the SipD39–343 residues that showed the largest chemical shift perturbations
(with ΔδHN > 0.05) were: S110, A111, L116, F117, Y149, L179, V187, K188 and T309
(Fig. 3A). Residues that showed significant chemical shift perturbations (with ΔδHN
between 0.03 – 0.05) were: A58, Q63, L87, and F109 (Fig. 3A). Taurodeoxycholate strongly
perturbed the same residues (with ΔδHN > 0.05) as deoxycholate in addition to E133 (Fig.
3B). For taurodeoxycholate, residues that showed significant chemical shift perturbations
(with ΔδHN between 0.03 – 0.05) were: E70, S96, F109, A115, L150, Y312 and L318 (Fig.
3B). Compared to deoxycholate and taurodeoxycholate, chenodeoxycholate had an overall
smaller effect on the chemical shifts of SipD (Fig. 3C). For chenodeoxycholate, the
strongest perturbations (having ΔδHN > 0.05) occurred in residues S110, A111 and F117;
with significant perturbations (having ΔδHN between 0.03–0.05) in residues Y149, T161,
L179, V187 and K188. Chenodeoxycholate perturbed generally the same subset of residues
perturbed by deoxycholate and taurodeoxycholate. Regarding the tryptophan side chain,
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both deoxycholate (Fig. 1B) and taurodeoxycholate (Fig. S7B) perturbed the W234 side
chain whereas chenodeoxycholate (Fig. S8B) did not.
A majority of the residues that were strongly perturbed by deoxycholate, taurodeoxycholate
and chenodeoxycholate were located on a 23-residue loop between residues 110–134, which
connects the N-terminal helix α1, α2 and α3 with the long central coiled-coil of SipD (Fig.
4). Another subset of residues perturbed by biles salts (residues L179, V187 and K188) was
located on beta strands β1 and β2 on the far end of the central coiled-coil and away from
loop 110–134 (Fig. 4). The N-terminal helix α1 and α2 also showed chemical shift
perturbations with deoxycholate (residues A58, Q63, and L87) and with taurodeoxycholate
(residues E70 and S96), albeit with lesser ΔδHN values compared to loop 110–134 and the
beta strands β1 and β2.
DISCUSSION
The major significance of this work is the NMR identification of SipD residues that were
perturbed by bile salts (Fig. 1, Fig. S7 & Fig. S8). This was made possible by our NMR
assignment of the backbone resonances of SipD (Fig. 2). To date, no other tip protein has
been assigned by NMR, and this is due to the challenge posed by NMR studies of the tip
proteins. SipD, IpaD and BipD have 343, 332, and 310 residues, respectively. Further, these
proteins were soluble only in submillimolar range, aggregated in NMR solution conditions
at high concentrations and showed poor quality NMR spectra that were unsuitable for NMR
characterization. The SipD N-terminal 38 residues, which were expected to be disordered
based on structural homology with BipD (11, 18) and IpaD (11), decreased the quality of
NMR data of full-length SipD (Fig. S1). A truncated construct, SipD39–343, retained the core
structure of SipD (Fig. S2) and showed the best quality NMR spectra (Fig. S1).
Perdeuteration, TROSY (Fig. S3) and amino acid-specific labeling (Fig. S4) were used to
obtain nearly complete backbone assignments for SipD39–343. All the SipD39–343 backbone
amide peaks that showed chemical shift perturbation with bile salts were assigned (Fig. 1,
Fig. S7 & Fig. S8). In addition, the tryptophan side chain peaks of SipD (Fig. S6), one of
which was perturbed by deoxycholate and taurodeoxycholate, were also assigned.
Another major finding of this work is that the bile salt binding site in SipD obtained from
NMR chemical shift mapping is inconsistent with the published model of IpaD-
deoxycholate interaction (7). Using the computer program AutoDock, Stensrud et al. (7)
reported a model of IpaD-deoxycholate complex where deoxycholate binds in a pocket at
the interface of the IpaD Nterminal region (equivalent to helix α1 and α2 of SipD, see Fig.
S5) and the long central coiled coil (equivalent to helix α4 and α8 of SipD) (Fig. 4). If the
model of the IpaD-deoxycholate interaction is applied to SipD, the N-terminal helix α1 and
α2 of SipD (residues 47–91) and the middle part of the coiled coil (helix α4 and α8 facing
helix α1 and α2) would be expected to show relatively the strongest chemical shift
perturbations with deoxycholate. However, in our NMR titrations, the N-terminal helix α1
and α2 of SipD did not show large chemical shift perturbations with deoxycholate (Fig. 3).
The helix α1 and α2 residues (A58, Q63 and L87) that were perturbed by deoxycholate
showed relatively smaller chemical shift perturbations compared to residues that showed the
largest chemical shift perturbations (Fig. 3). And in helix α8, only one residue (T309)
showed chemical shift perturbation above the threshold of significance (at ΔδHN = 0.03).
The relatively smaller chemical shift perturbations and the paucity of residues affected lead
us to conclude that helix α1, α2 and α8 are not the primary binding site for deoxycholate in
SipD. Instead, for deoxycholate, taurodeoxychoate and chenodeoxycholate, the strongest
chemical shift perturbations occurred in loop 110–134 (Fig. 3 & Fig. 4), which connects the
N-terminal region (helix α1 – α3) to the central coiled coil (helix α4 and α8). Our NMR
results suggest that in SipD, loop 110–134 is most likely involved in interaction with bile
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salts. Residues L179, V187 and K188 located on beta strands β1 and β2 (Fig. 4) also showed
consistently significant chemical shift perturbations (Fig. 3), however these residues are far
away from loop 110–134 (Fig. 4). Thus, the chemical shift perturbation of L179, V187 and
K188 is possibly due to non-specific interaction with bile salts. Based on our chemical shift
mapping, we conclude that SipD bind bile salts in a different manner as predicted for IpaD
(7) despite strong structural similarity between IpaD and SipD (with Cα RMSD of 1.4 Å)
(Fig. S5).
We propose that the difference in the interaction between IpaD and SipD to bile salts reflects
the differing responses of Shigella and Salmonella T3SS to bile salts. Bile salts activate the
Shigella T3SS (7, 8), whereas they repress the Salmonella T3SS (9). In Salmonella, bile
salts repress the transcription of T3SS genes and reduce the secretion of T3SS effectors (9,
10, 21). The precise target of bile salts vis-à-vis T3SS transcriptional regulation is currently
unknown (9, 10). Bile salts do not interact directly with any of the T3SS transcriptional
regulators (HilA and SirC) (9). Prouty and Gunn (9) hypothesized that bile salts enter the
T3SS regulatory pathway through the two-component system SirA-BarA (which regulates
HilA and SirC) or some unknown factor that affects the activity of SirA-BarA. On the other
hand, others have shown recently that IpaD is present at the tip of the Shigella needle prior
to contact with eukaryotic cells (3). In the presence of bile salts, bile salts interact with IpaD
and trigger the release of IpaB (8), a protein involved in the assembly of the translocon (a
membrane spanning structure that punctures a hole in the eukaryotic cell membrane to allow
the passage of bacterial proteins). Similarly in Salmonella, Lara-Tejero & Galan (22) have
shown that SipD is present on the bacterial surface before contact with eukaryotic cells, and
upon contact with eukaryotic cells, the translocator proteins SipB and SipC are released.
Thus, in Shigella and Salmonella, there is a period when IpaD and SipD are present at the tip
of the needle (3, 8, 22) when they could act as environmental sensors by interacting directly
with bile salts. Our results, together with the results of Stensrud et al. (7) suggest a model of
tip protein-bile salt interaction where IpaD and SipD have different binding sites for bile
salts. One site (the IpaD site), results to activation of the T3SS by allowing the assembly of
the transcolon, and another site (the SipD site), results to inactivation of the T3SS.
Although the use of truncated SipD facilitated the NMR studies reported here, it also
prevented the determination of the role of the SipD N-terminal 38 residues with respect to
bile salt interaction. It is expected, however, that the main function of the N-terminal region
is as a type III secretion signal (23, 24) rather than for bile-salt interaction. Another
limitation of the current work is that the NMR method used here could not determine the Kd
of the SipD-bile salt interaction, which is needed for functional studies of SipD-bile salt
interaction. The reason for this is that the chemical shift changes did not reach saturation
during the titration. Increasing the amount of bile salts was not possible because of the
limitation imposed by the millimolar CMCs of bile salts and the requirement for
submillimolar amounts of Sipd39–343 for NMR. Because of the poor quality of the NMR
spectrum of the full-length SipD (Fig. S1B), it was also not possible to use the full-length
SipD in binding studies by NMR methods. Isothermal calorimetry also failed to determine
the Kd because the heat generated by (full-length and truncated) SipD upon titration with
bile salts was lower than the heat generated by micelle formation of bile salts (19). Thus, a
more sensitive method such as fluorescence spectroscopy, which was successfully used in
studies of IpaD-bile salt interaction (7), would have to be used to determine the Kd of
SipDbile salt interaction.
In summary, we have used NMR methods to investigate the interaction of SipD with bile
salts and found that the interaction is different from what was predicted for IpaD-bile salt
interaction. The differing response of SipD and IpaD to bile salts is most likely related to the
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opposing responses of Shigella and Salmonella to bile salts. Our results presented herein
contribute to our understanding of the molecular interactions involved in type III secretion.
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ABBREVIATIONS AND TEXTUAL FOOTNOTES
CMC critical micelle concentration
HSQC heteronuclear single quantum coherence spectroscopy
Kd dissociation constant
NMR nuclear magnetic resonance spectroscopy
RMSD root mean square deviation
TEV tobacco etch virus
T3SS type III secretion system
T3SS type III secretion system
TROSY transverse relaxation spectroscopy
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(A) Overlay of four 2D 1H-15N TROSY spectra of [2H,15N,13C]-labeled SipD39–343 with
increasing amounts of deoxycholate. Some of the assignments are indicated as well as the
noise peaks (*). (B) Expanded regions of the 2D 1H-15N TROSY spectra for specific
residues that showed chemical shift changes with deoxycholate (arrows indicate the
direction of the chemical shift change). Similar NMR titration data for SipD39–343 with
taurodeoxycholate (Fig. S7), chenodeoxycholate (Fig. S8) and cholate hydrate (Fig. S9) are
shown in the Supporting Information.
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Secondary structures of SipD39–343 based on the (A) Cα, (B) Cβ and (C) C’ secondary NMR
chemical shifts. The secondary structures of the SipD39–343 crystal are also shown and are
denoted by arrow (beta strand), wavy line (helix); solid line (loop), and broken line
(disordered loop). Residues 118–133 lacked electron density in the SipD39–343 crystal.
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Weighted chemical shift difference (ΔδHN) of the 1H and 15N resonances of SipD39–343
when titrated with (A) deoxycholate, (B) taurodeoxycholate and (C) chenodeoxycholate
(ΔδHN = [½ (δH2 + 1/25δN2)]1/2 (25)). The 1H and 15N chemical shifts were extracted from
the 2D 1H-15N TROSY spectra of the free protein and the protein with the highest molar
ratios of titrants at (A) 3.5, (B) 3.7 and (C) 4.3, respectively. For the deoxycholate titration
(A), the average ΔδHN for all residues was 0.011 ppm with a standard deviation (σ) of 0.011
ppm. Thus, ΔδHN values above 3σ (or 0.03 ppm, indicated by a horizontal line) were
deemed significant. Horizontal lines at ΔδHN 0.03 ppm in (B) and (C) were drawn for
comparison with (A).
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Ribbon representation of the crystal structure of SipD39–343 (to be reported elsewhere). The
side chains of residues that showed significant chemical shift perturbation (ΔδHN > 0.03)
with deoxycholate were colored red (legend: α, α-helix; β, beta strand; dark oval represents
the equivalent region in IpaD that was predicted by computer docking to be deoxycholate
binding site in IpaD (7)). The various regions of SipD were colored as follows: N-terminal
helix α1 and α2 (light blue), helix α3 and loop 110–117 (light green), the central coiled coil
formed by helix α4 and α8 (gray), and the rest of SipD (pale cyan).
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